Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.61203204 |
2 | negative T cell selection (GO:0043383) | 6.56985523 |
3 | regulation of isotype switching to IgG isotypes (GO:0048302) | 6.48899803 |
4 | negative thymic T cell selection (GO:0045060) | 6.34388344 |
5 | negative regulation of cell killing (GO:0031342) | 6.14461499 |
6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.14461499 |
7 | interferon-gamma production (GO:0032609) | 6.13682590 |
8 | cellular response to interleukin-15 (GO:0071350) | 5.60359388 |
9 | positive thymic T cell selection (GO:0045059) | 5.57796149 |
10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.47283227 |
11 | response to interleukin-15 (GO:0070672) | 5.33559304 |
12 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.26935221 |
13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.26935221 |
14 | thymic T cell selection (GO:0045061) | 5.18263965 |
15 | positive T cell selection (GO:0043368) | 5.16133103 |
16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.14439665 |
17 | positive regulation of isotype switching (GO:0045830) | 4.99013741 |
18 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.95816717 |
19 | leukocyte aggregation (GO:0070486) | 4.86196156 |
20 | regulation of gamma-delta T cell activation (GO:0046643) | 4.86090023 |
21 | T cell selection (GO:0045058) | 4.83195534 |
22 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.78293034 |
23 | T cell migration (GO:0072678) | 4.70537171 |
24 | positive regulation of DNA recombination (GO:0045911) | 4.45861482 |
25 | regulation of isotype switching (GO:0045191) | 4.41418839 |
26 | * regulation of B cell receptor signaling pathway (GO:0050855) | 4.39090909 |
27 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.28356127 |
28 | tolerance induction (GO:0002507) | 4.25901377 |
29 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.25767027 |
30 | positive regulation of B cell differentiation (GO:0045579) | 4.22420783 |
31 | T cell costimulation (GO:0031295) | 4.22369835 |
32 | lymphocyte costimulation (GO:0031294) | 4.21925082 |
33 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.19221498 |
34 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 4.16763747 |
35 | positive regulation of B cell mediated immunity (GO:0002714) | 4.16763747 |
36 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.14595665 |
37 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.07566909 |
38 | * T cell receptor signaling pathway (GO:0050852) | 4.05208413 |
39 | regulation of T cell tolerance induction (GO:0002664) | 3.96972341 |
40 | cytidine deamination (GO:0009972) | 3.95348879 |
41 | cytidine metabolic process (GO:0046087) | 3.95348879 |
42 | cytidine catabolic process (GO:0006216) | 3.95348879 |
43 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.92989800 |
44 | regulation of regulatory T cell differentiation (GO:0045589) | 3.91616535 |
45 | regulation of B cell mediated immunity (GO:0002712) | 3.88230292 |
46 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.83541561 |
47 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.83541561 |
48 | activated T cell proliferation (GO:0050798) | 3.81430494 |
49 | * antigen receptor-mediated signaling pathway (GO:0050851) | 3.77385450 |
50 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.74594410 |
51 | * regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.73950115 |
52 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.73788022 |
53 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.73788022 |
54 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.70827348 |
55 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.70477044 |
56 | negative regulation of T cell mediated immunity (GO:0002710) | 3.68243286 |
57 | immunoglobulin mediated immune response (GO:0016064) | 3.67490451 |
58 | * regulation of T cell receptor signaling pathway (GO:0050856) | 3.57788999 |
59 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.56541639 |
60 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.55796740 |
61 | positive regulation of immunoglobulin production (GO:0002639) | 3.54416638 |
62 | regulation of response to interferon-gamma (GO:0060330) | 3.54002991 |
63 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.52532270 |
64 | mast cell activation (GO:0045576) | 3.51942354 |
65 | positive regulation of interleukin-2 production (GO:0032743) | 3.51836976 |
66 | regulation of cell killing (GO:0031341) | 3.48090806 |
67 | regulation of B cell differentiation (GO:0045577) | 3.47744709 |
68 | positive regulation of cell killing (GO:0031343) | 3.45163991 |
69 | alpha-beta T cell activation (GO:0046631) | 3.43908227 |
70 | neutrophil activation involved in immune response (GO:0002283) | 3.43007921 |
71 | regulation of immunoglobulin production (GO:0002637) | 3.41702714 |
72 | positive regulation of granulocyte differentiation (GO:0030854) | 3.39576921 |
73 | alpha-beta T cell differentiation (GO:0046632) | 3.38547952 |
74 | detection of other organism (GO:0098543) | 3.36703874 |
75 | B cell receptor signaling pathway (GO:0050853) | 3.36098067 |
76 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.34712156 |
77 | detection of bacterium (GO:0016045) | 3.33978546 |
78 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.32752782 |
79 | T cell differentiation involved in immune response (GO:0002292) | 3.32752782 |
80 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.32752782 |
81 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.32132746 |
82 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.32128337 |
83 | cellular extravasation (GO:0045123) | 3.29446926 |
84 | * T cell differentiation (GO:0030217) | 3.26443831 |
85 | positive regulation of humoral immune response (GO:0002922) | 3.24378663 |
86 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.22558011 |
87 | B cell mediated immunity (GO:0019724) | 3.21001869 |
88 | negative regulation of B cell proliferation (GO:0030889) | 3.19954649 |
89 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.18989273 |
90 | defense response to protozoan (GO:0042832) | 3.18708560 |
91 | negative regulation of interleukin-12 production (GO:0032695) | 3.17587325 |
92 | T-helper cell differentiation (GO:0042093) | 3.17564404 |
93 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.17564404 |
94 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.15117722 |
95 | regulation of chronic inflammatory response (GO:0002676) | 3.14791206 |
96 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.14128946 |
97 | T cell homeostasis (GO:0043029) | 3.13593279 |
98 | neutrophil activation (GO:0042119) | 3.13378725 |
99 | response to protozoan (GO:0001562) | 3.13268485 |
100 | actin nucleation (GO:0045010) | 3.12891751 |
101 | NIK/NF-kappaB signaling (GO:0038061) | 3.11649247 |
102 | myeloid dendritic cell activation (GO:0001773) | 3.11457373 |
103 | positive regulation by symbiont of host defense response (GO:0052509) | 3.11323654 |
104 | modulation by symbiont of host defense response (GO:0052031) | 3.11323654 |
105 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.11323654 |
106 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.11323654 |
107 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.11323654 |
108 | modulation by symbiont of host immune response (GO:0052553) | 3.11323654 |
109 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.10743565 |
110 | leukocyte cell-cell adhesion (GO:0007159) | 3.10378157 |
111 | granulocyte activation (GO:0036230) | 3.09852416 |
112 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.09048498 |
113 | response to type I interferon (GO:0034340) | 3.08843741 |
114 | myeloid cell activation involved in immune response (GO:0002275) | 3.08806952 |
115 | positive regulation of tolerance induction (GO:0002645) | 3.08496731 |
116 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.08165580 |
117 | type I interferon signaling pathway (GO:0060337) | 3.07751265 |
118 | cellular response to type I interferon (GO:0071357) | 3.07751265 |
119 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.06066219 |
120 | natural killer cell activation (GO:0030101) | 3.05505743 |
121 | leukocyte degranulation (GO:0043299) | 3.02607585 |
122 | T cell activation involved in immune response (GO:0002286) | 3.01463531 |
123 | * T cell activation (GO:0042110) | 2.99636750 |
124 | positive regulation of B cell activation (GO:0050871) | 2.99590737 |
125 | T cell lineage commitment (GO:0002360) | 2.98900964 |
126 | regulation of tolerance induction (GO:0002643) | 2.97969601 |
127 | cellular defense response (GO:0006968) | 2.97173354 |
128 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.96418666 |
129 | DNA deamination (GO:0045006) | 2.95979427 |
130 | response to peptidoglycan (GO:0032494) | 2.92583745 |
131 | regulation of alpha-beta T cell activation (GO:0046634) | 2.90152387 |
132 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.87875097 |
133 | T cell proliferation (GO:0042098) | 2.87621293 |
134 | positive regulation of defense response to virus by host (GO:0002230) | 2.87462345 |
135 | response to muramyl dipeptide (GO:0032495) | 2.87044134 |
136 | regulation of antigen processing and presentation (GO:0002577) | 2.86010702 |
137 | dendritic cell chemotaxis (GO:0002407) | 2.83917470 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 8.03967679 |
2 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.05368915 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.61200960 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.42797864 |
5 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.96470487 |
6 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.72963574 |
7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.69443396 |
8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.52794039 |
9 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.51766122 |
10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.48360609 |
11 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.45895635 |
12 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.36291831 |
13 | * MYB_26560356_Chip-Seq_TH2_Human | 3.13404243 |
14 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 3.11302142 |
15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.08631042 |
16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.07783284 |
17 | MYC_22102868_ChIP-Seq_BL_Human | 2.63119749 |
18 | * MYB_26560356_Chip-Seq_TH1_Human | 2.61335981 |
19 | MAF_26560356_Chip-Seq_TH1_Human | 2.58183214 |
20 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.50139854 |
21 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.48283525 |
22 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.40465014 |
23 | GATA1_22025678_ChIP-Seq_K562_Human | 2.39108313 |
24 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.36130296 |
25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.33316601 |
26 | UTX_26944678_Chip-Seq_JUKART_Human | 2.25721427 |
27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.20462093 |
28 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.20275061 |
29 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.16624066 |
30 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.13275582 |
31 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.01418854 |
32 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.00404317 |
33 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98426088 |
34 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.96520184 |
35 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.85634270 |
36 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.78343785 |
37 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.75903835 |
38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75464560 |
39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.71210779 |
40 | MAF_26560356_Chip-Seq_TH2_Human | 1.68428119 |
41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.63539246 |
42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.61985134 |
43 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.56769094 |
44 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.53479249 |
45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.53164029 |
46 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53149925 |
47 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48697945 |
48 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.47836858 |
49 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44411003 |
50 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42859584 |
51 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.42630390 |
52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.40876473 |
53 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.34060966 |
54 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.32831730 |
55 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.30435004 |
56 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.30356155 |
57 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.25887260 |
58 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.24975114 |
59 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.22529601 |
60 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.22272474 |
61 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20613783 |
62 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.18758179 |
63 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17693303 |
64 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17412438 |
65 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.14668329 |
66 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.10946782 |
67 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.10880658 |
68 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09823807 |
69 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.09445178 |
70 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06412522 |
71 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.05294253 |
72 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03851834 |
73 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.03541115 |
74 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.99968745 |
75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99295516 |
76 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.98918694 |
77 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.97481452 |
78 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.96560532 |
79 | GATA3_26560356_Chip-Seq_TH1_Human | 0.95617808 |
80 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95572732 |
81 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.95537186 |
82 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.94451406 |
83 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.93797172 |
84 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93717743 |
85 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.93094794 |
86 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.89913864 |
87 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.87560308 |
88 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.87276113 |
89 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86252994 |
90 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86149883 |
91 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.83718971 |
92 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.82742579 |
93 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.82435443 |
94 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80565555 |
95 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.80376280 |
96 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80075282 |
97 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79917588 |
98 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.78912581 |
99 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.78222955 |
100 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.77044862 |
101 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75954089 |
102 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74507912 |
103 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.72776798 |
104 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.72592724 |
105 | P300_27268052_Chip-Seq_Bcells_Human | 0.71428669 |
106 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71426858 |
107 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.68124155 |
108 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.67694088 |
109 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.67168635 |
110 | GATA1_19941826_ChIP-Seq_K562_Human | 0.66995707 |
111 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.66426084 |
112 | GATA2_19941826_ChIP-Seq_K562_Human | 0.66178184 |
113 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.65985993 |
114 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.65354525 |
115 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.64186390 |
116 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.62982682 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005671_abnormal_response_to | 5.05362064 |
2 | * MP0003763_abnormal_thymus_physiology | 4.62543769 |
3 | MP0001835_abnormal_antigen_presentation | 4.19236461 |
4 | MP0009785_altered_susceptibility_to | 3.34617944 |
5 | MP0000685_abnormal_immune_system | 3.30980779 |
6 | * MP0001800_abnormal_humoral_immune | 3.26123484 |
7 | MP0005387_immune_system_phenotype | 3.08974772 |
8 | MP0001790_abnormal_immune_system | 3.08974772 |
9 | * MP0005000_abnormal_immune_tolerance | 3.05499742 |
10 | MP0001873_stomach_inflammation | 2.88399156 |
11 | MP0009333_abnormal_splenocyte_physiolog | 2.87681259 |
12 | * MP0002723_abnormal_immune_serum | 2.84870240 |
13 | * MP0002420_abnormal_adaptive_immunity | 2.82983874 |
14 | * MP0001819_abnormal_immune_cell | 2.80206690 |
15 | MP0005025_abnormal_response_to | 2.75667867 |
16 | * MP0002452_abnormal_antigen_presenting | 2.72480028 |
17 | MP0006082_CNS_inflammation | 2.67669458 |
18 | * MP0002398_abnormal_bone_marrow | 2.64780468 |
19 | MP0003436_decreased_susceptibility_to | 2.64180444 |
20 | MP0002166_altered_tumor_susceptibility | 2.56662797 |
21 | MP0003724_increased_susceptibility_to | 2.53370578 |
22 | * MP0002405_respiratory_system_inflammati | 2.43028208 |
23 | MP0002148_abnormal_hypersensitivity_rea | 2.41210896 |
24 | * MP0000716_abnormal_immune_system | 2.36116534 |
25 | MP0002396_abnormal_hematopoietic_system | 2.27011681 |
26 | MP0000703_abnormal_thymus_morphology | 2.24562127 |
27 | MP0002006_tumorigenesis | 2.24141764 |
28 | MP0002419_abnormal_innate_immunity | 2.17197296 |
29 | MP0010155_abnormal_intestine_physiology | 2.15996993 |
30 | * MP0002722_abnormal_immune_system | 2.11184353 |
31 | * MP0000689_abnormal_spleen_morphology | 2.08355528 |
32 | MP0001853_heart_inflammation | 2.07454380 |
33 | MP0003303_peritoneal_inflammation | 2.01917041 |
34 | * MP0002429_abnormal_blood_cell | 1.92882316 |
35 | MP0003300_gastrointestinal_ulcer | 1.86819273 |
36 | MP0004947_skin_inflammation | 1.85275945 |
37 | MP0003866_abnormal_defecation | 1.85163013 |
38 | MP0005464_abnormal_platelet_physiology | 1.77267952 |
39 | MP0002933_joint_inflammation | 1.73919052 |
40 | * MP0001845_abnormal_inflammatory_respons | 1.72218757 |
41 | MP0000858_altered_metastatic_potential | 1.68297695 |
42 | MP0005075_abnormal_melanosome_morpholog | 1.64587087 |
43 | MP0004381_abnormal_hair_follicle | 1.58215249 |
44 | MP0003172_abnormal_lysosome_physiology | 1.47990816 |
45 | MP0005310_abnormal_salivary_gland | 1.46139380 |
46 | MP0000490_abnormal_crypts_of | 1.45718065 |
47 | MP0000465_gastrointestinal_hemorrhage | 1.44518507 |
48 | MP0004510_myositis | 1.40938661 |
49 | MP0002132_abnormal_respiratory_system | 1.38870660 |
50 | MP0004808_abnormal_hematopoietic_stem | 1.38426738 |
51 | MP0003183_abnormal_peptide_metabolism | 1.36081036 |
52 | MP0005174_abnormal_tail_pigmentation | 1.35174198 |
53 | MP0003448_altered_tumor_morphology | 1.27145499 |
54 | MP0001533_abnormal_skeleton_physiology | 1.26742646 |
55 | MP0008469_abnormal_protein_level | 1.21457184 |
56 | MP0008057_abnormal_DNA_replication | 1.17799726 |
57 | MP0002009_preneoplasia | 1.16613290 |
58 | MP0003191_abnormal_cellular_cholesterol | 1.13713478 |
59 | MP0000015_abnormal_ear_pigmentation | 1.12283382 |
60 | MP0005397_hematopoietic_system_phenotyp | 1.11900628 |
61 | MP0001545_abnormal_hematopoietic_system | 1.11900628 |
62 | MP0002019_abnormal_tumor_incidence | 1.00018692 |
63 | MP0001851_eye_inflammation | 0.98350503 |
64 | MP0002998_abnormal_bone_remodeling | 0.98090435 |
65 | MP0003828_pulmonary_edema | 0.92667300 |
66 | MP0008007_abnormal_cellular_replicative | 0.88776010 |
67 | MP0002095_abnormal_skin_pigmentation | 0.87772852 |
68 | MP0003075_altered_response_to | 0.86366026 |
69 | MP0005451_abnormal_body_composition | 0.85816312 |
70 | MP0009764_decreased_sensitivity_to | 0.81600225 |
71 | MP0001663_abnormal_digestive_system | 0.81597623 |
72 | MP0002163_abnormal_gland_morphology | 0.81163223 |
73 | MP0010094_abnormal_chromosome_stability | 0.77237457 |
74 | MP0003693_abnormal_embryo_hatching | 0.75715429 |
75 | MP0008058_abnormal_DNA_repair | 0.74180284 |
76 | MP0003656_abnormal_erythrocyte_physiolo | 0.73176435 |
77 | MP0009763_increased_sensitivity_to | 0.72077063 |
78 | MP0005058_abnormal_lysosome_morphology | 0.70995540 |
79 | MP0003077_abnormal_cell_cycle | 0.70304129 |
80 | MP0000604_amyloidosis | 0.70013052 |
81 | MP0003806_abnormal_nucleotide_metabolis | 0.69377916 |
82 | MP0000569_abnormal_digit_pigmentation | 0.66944295 |
83 | MP0003045_fibrosis | 0.66548915 |
84 | MP0008260_abnormal_autophagy | 0.59562182 |
85 | MP0002277_abnormal_respiratory_mucosa | 0.58444279 |
86 | MP0005166_decreased_susceptibility_to | 0.58273516 |
87 | MP0003795_abnormal_bone_structure | 0.57490454 |
88 | MP0002138_abnormal_hepatobiliary_system | 0.56585364 |
89 | MP0009765_abnormal_xenobiotic_induced | 0.56392450 |
90 | MP0000372_irregular_coat_pigmentation | 0.56102771 |
91 | MP0001986_abnormal_taste_sensitivity | 0.55758901 |
92 | MP0004883_abnormal_blood_vessel | 0.55338447 |
93 | MP0003252_abnormal_bile_duct | 0.54550202 |
94 | MP0005390_skeleton_phenotype | 0.54509506 |
95 | MP0010307_abnormal_tumor_latency | 0.54110872 |
96 | MP0001881_abnormal_mammary_gland | 0.52315853 |
97 | MP0002693_abnormal_pancreas_physiology | 0.51693113 |
98 | MP0000371_diluted_coat_color | 0.50688546 |
99 | MP0000343_altered_response_to | 0.49793214 |
100 | MP0000477_abnormal_intestine_morphology | 0.48676536 |
101 | MP0003786_premature_aging | 0.47654381 |
102 | MP0001765_abnormal_ion_homeostasis | 0.46263937 |
103 | MP0002876_abnormal_thyroid_physiology | 0.45714903 |
104 | * MP0000609_abnormal_liver_physiology | 0.44684399 |
105 | * MP0002136_abnormal_kidney_physiology | 0.44592437 |
106 | MP0000313_abnormal_cell_death | 0.44368803 |
107 | MP0003690_abnormal_glial_cell | 0.44008344 |
108 | MP0009278_abnormal_bone_marrow | 0.43833875 |
109 | MP0000249_abnormal_blood_vessel | 0.42992005 |
110 | MP0005164_abnormal_response_to | 0.42535413 |
111 | MP0001191_abnormal_skin_condition | 0.42237741 |
112 | MP0001348_abnormal_lacrimal_gland | 0.42052860 |
113 | MP0005379_endocrine/exocrine_gland_phen | 0.42007728 |
114 | MP0008961_abnormal_basal_metabolism | 0.41836825 |
115 | MP0009840_abnormal_foam_cell | 0.41670401 |
116 | MP0003111_abnormal_nucleus_morphology | 0.40962985 |
117 | MP0001919_abnormal_reproductive_system | 0.40795823 |
118 | MP0003943_abnormal_hepatobiliary_system | 0.39468335 |
119 | MP0005023_abnormal_wound_healing | 0.38845924 |
120 | MP0001216_abnormal_epidermal_layer | 0.36673265 |
121 | MP0004782_abnormal_surfactant_physiolog | 0.35937105 |
122 | MP0004957_abnormal_blastocyst_morpholog | 0.35720815 |
Rank | Gene Set | Z-score |
---|---|---|
1 | T lymphocytopenia (HP:0005403) | 6.21881955 |
2 | Abnormality of T cell number (HP:0011839) | 5.99932484 |
3 | Myositis (HP:0100614) | 5.43849907 |
4 | Retrobulbar optic neuritis (HP:0100654) | 5.21851612 |
5 | Optic neuritis (HP:0100653) | 5.21851612 |
6 | Stomatitis (HP:0010280) | 5.15070390 |
7 | Severe combined immunodeficiency (HP:0004430) | 5.12735274 |
8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.07698697 |
9 | Abnormality of T cells (HP:0002843) | 4.77826230 |
10 | Combined immunodeficiency (HP:0005387) | 4.64595805 |
11 | Orchitis (HP:0100796) | 4.62617946 |
12 | IgM deficiency (HP:0002850) | 4.41091291 |
13 | Recurrent bronchitis (HP:0002837) | 4.36714196 |
14 | Recurrent fungal infections (HP:0002841) | 4.35076497 |
15 | IgG deficiency (HP:0004315) | 4.29594454 |
16 | Eczematoid dermatitis (HP:0000976) | 4.25086196 |
17 | Panhypogammaglobulinemia (HP:0003139) | 4.15726401 |
18 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.08969692 |
19 | Recurrent cutaneous fungal infections (HP:0011370) | 4.08969692 |
20 | Recurrent viral infections (HP:0004429) | 3.94836715 |
21 | Abnormality of B cell number (HP:0010975) | 3.93735449 |
22 | B lymphocytopenia (HP:0010976) | 3.93735449 |
23 | Thyroiditis (HP:0100646) | 3.88464053 |
24 | Chronic otitis media (HP:0000389) | 3.86790561 |
25 | Recurrent abscess formation (HP:0002722) | 3.85363781 |
26 | * Meningitis (HP:0001287) | 3.70741301 |
27 | Abnormality of eosinophils (HP:0001879) | 3.65381626 |
28 | Keratoconjunctivitis sicca (HP:0001097) | 3.58070345 |
29 | Chronic diarrhea (HP:0002028) | 3.54138017 |
30 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.52883741 |
31 | Increased IgM level (HP:0003496) | 3.50899175 |
32 | Encephalitis (HP:0002383) | 3.50265399 |
33 | Nasal polyposis (HP:0100582) | 3.48458520 |
34 | Abnormality of T cell physiology (HP:0011840) | 3.43246246 |
35 | * Vasculitis (HP:0002633) | 3.38070055 |
36 | Keratoconjunctivitis (HP:0001096) | 3.33360051 |
37 | Lymphopenia (HP:0001888) | 3.29152432 |
38 | Agammaglobulinemia (HP:0004432) | 3.25364100 |
39 | Leukocytosis (HP:0001974) | 3.25357989 |
40 | Autoimmune hemolytic anemia (HP:0001890) | 3.17532787 |
41 | Eosinophilia (HP:0001880) | 3.17517815 |
42 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.16399730 |
43 | * Pulmonary infiltrates (HP:0002113) | 3.15283932 |
44 | * Hemoptysis (HP:0002105) | 3.13615377 |
45 | Thrombocytosis (HP:0001894) | 3.12243638 |
46 | Pustule (HP:0200039) | 3.01788246 |
47 | Recurrent bacterial skin infections (HP:0005406) | 2.99381274 |
48 | Lymphoma (HP:0002665) | 2.96437261 |
49 | Recurrent sinusitis (HP:0011108) | 2.95221596 |
50 | Recurrent skin infections (HP:0001581) | 2.92381127 |
51 | Cheilitis (HP:0100825) | 2.90093280 |
52 | Abnormality of the nasal mucosa (HP:0000433) | 2.88684725 |
53 | * Chronic obstructive pulmonary disease (HP:0006510) | 2.87941603 |
54 | * Obstructive lung disease (HP:0006536) | 2.87941603 |
55 | Granulocytopenia (HP:0001913) | 2.86414703 |
56 | Autoimmune thrombocytopenia (HP:0001973) | 2.85554570 |
57 | IgA deficiency (HP:0002720) | 2.80036210 |
58 | Abnormality of the fingertips (HP:0001211) | 2.77866931 |
59 | Inflammation of the large intestine (HP:0002037) | 2.71189708 |
60 | * Mediastinal lymphadenopathy (HP:0100721) | 2.68676796 |
61 | Urticaria (HP:0001025) | 2.66300632 |
62 | Gastrointestinal inflammation (HP:0004386) | 2.62399878 |
63 | Hypoplasia of the thymus (HP:0000778) | 2.58687890 |
64 | Papilledema (HP:0001085) | 2.56536840 |
65 | * Gastrointestinal infarctions (HP:0005244) | 2.52330096 |
66 | * Abnormality of the prostate (HP:0008775) | 2.51041434 |
67 | Hypergammaglobulinemia (HP:0010702) | 2.42974514 |
68 | Papilloma (HP:0012740) | 2.41669221 |
69 | Verrucae (HP:0200043) | 2.41669221 |
70 | Keratitis (HP:0000491) | 2.38867489 |
71 | Bronchitis (HP:0012387) | 2.37625581 |
72 | * Arterial thrombosis (HP:0004420) | 2.36161086 |
73 | * Joint swelling (HP:0001386) | 2.33477584 |
74 | Prolonged bleeding time (HP:0003010) | 2.32092923 |
75 | Acute hepatic failure (HP:0006554) | 2.31228500 |
76 | Osteomyelitis (HP:0002754) | 2.26765658 |
77 | Petechiae (HP:0000967) | 2.26566494 |
78 | Hypoproteinemia (HP:0003075) | 2.25786490 |
79 | * Epistaxis (HP:0000421) | 2.25690121 |
80 | * Skin rash (HP:0000988) | 2.23403406 |
81 | Gastrointestinal stroma tumor (HP:0100723) | 2.22237252 |
82 | Spontaneous hematomas (HP:0007420) | 2.21057693 |
83 | * Abnormality of the pleura (HP:0002103) | 2.19356960 |
84 | Periodontitis (HP:0000704) | 2.19117104 |
85 | Gingivitis (HP:0000230) | 2.19066601 |
86 | Gingival bleeding (HP:0000225) | 2.15424905 |
87 | Hypochromic anemia (HP:0001931) | 2.12459121 |
88 | Increased IgE level (HP:0003212) | 2.10732584 |
89 | Abnormality of macrophages (HP:0004311) | 2.09396433 |
90 | Sepsis (HP:0100806) | 2.08107073 |
91 | Chronic sinusitis (HP:0011109) | 2.06836353 |
92 | * Gangrene (HP:0100758) | 2.04312644 |
93 | Abnormality of glycolipid metabolism (HP:0010969) | 2.01747217 |
94 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.01747217 |
95 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.01747217 |
96 | * Glomerulopathy (HP:0100820) | 2.01414652 |
97 | Prostate neoplasm (HP:0100787) | 1.98712653 |
98 | * Pulmonary embolism (HP:0002204) | 1.96178079 |
99 | Fatigue (HP:0012378) | 1.96073420 |
100 | Alveolar cell carcinoma (HP:0006519) | 1.95782108 |
101 | * Restrictive lung disease (HP:0002091) | 1.91127739 |
102 | Premature loss of primary teeth (HP:0006323) | 1.88430439 |
103 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.87613413 |
104 | Colitis (HP:0002583) | 1.86589218 |
105 | Aplastic anemia (HP:0001915) | 1.84958595 |
106 | Emphysema (HP:0002097) | 1.84152555 |
107 | Abnormality of the endocardium (HP:0004306) | 1.81683450 |
108 | Reduced antithrombin III activity (HP:0001976) | 1.81564764 |
109 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.80501781 |
110 | * Arthralgia (HP:0002829) | 1.79497330 |
111 | Cellulitis (HP:0100658) | 1.78394947 |
112 | * Chest pain (HP:0100749) | 1.78183865 |
113 | Recurrent otitis media (HP:0000403) | 1.77644561 |
114 | Neutropenia (HP:0001875) | 1.77111166 |
115 | Type I transferrin isoform profile (HP:0003642) | 1.75921903 |
116 | * Skin ulcer (HP:0200042) | 1.75800367 |
117 | Acute myeloid leukemia (HP:0004808) | 1.75302275 |
118 | Recurrent pneumonia (HP:0006532) | 1.73943459 |
119 | Bronchiectasis (HP:0002110) | 1.73378847 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TXK | 7.43642374 |
2 | MAP4K1 | 5.16891286 |
3 | ITK | 3.34604379 |
4 | JAK3 | 2.85030119 |
5 | MAP3K14 | 2.78716363 |
6 | ZAP70 | 2.67550474 |
7 | TEC | 2.56847488 |
8 | IKBKE | 2.48727749 |
9 | NLK | 2.25832535 |
10 | TYK2 | 2.15440591 |
11 | JAK1 | 2.08355501 |
12 | IRAK4 | 2.05270208 |
13 | BTK | 1.97927643 |
14 | STK10 | 1.85413955 |
15 | TBK1 | 1.81405859 |
16 | LCK | 1.77172684 |
17 | FGFR4 | 1.70952615 |
18 | IKBKB | 1.66234373 |
19 | NME2 | 1.65238419 |
20 | CSK | 1.59627884 |
21 | KIT | 1.57113547 |
22 | SYK | 1.55293693 |
23 | GRK6 | 1.46528463 |
24 | IRAK3 | 1.43364654 |
25 | MST4 | 1.41216499 |
26 | HCK | 1.40795600 |
27 | SIK3 | 1.39859042 |
28 | BLK | 1.39714034 |
29 | FGFR3 | 1.39362396 |
30 | PIK3CG | 1.23590357 |
31 | TAOK2 | 1.21699058 |
32 | PRPF4B | 1.20491361 |
33 | CLK1 | 1.19944866 |
34 | TAOK3 | 1.16135057 |
35 | FES | 1.14439164 |
36 | CAMKK2 | 1.13943781 |
37 | PIM1 | 1.13430545 |
38 | MAP2K3 | 1.12760891 |
39 | MATK | 1.12299979 |
40 | MAP3K12 | 1.09926883 |
41 | MAP3K13 | 1.08702206 |
42 | CHUK | 1.07220165 |
43 | LYN | 1.02762128 |
44 | TAOK1 | 0.95196577 |
45 | MARK3 | 0.94354029 |
46 | ERN1 | 0.92343183 |
47 | PRKCQ | 0.90519116 |
48 | KDR | 0.88822668 |
49 | TNIK | 0.81468739 |
50 | TNK2 | 0.79330737 |
51 | TGFBR2 | 0.77502606 |
52 | JAK2 | 0.75154660 |
53 | CSF1R | 0.74826118 |
54 | SIK2 | 0.74584807 |
55 | FGR | 0.70292883 |
56 | IRAK1 | 0.70156300 |
57 | FRK | 0.68177554 |
58 | MAP3K11 | 0.67795492 |
59 | MAP2K2 | 0.67449500 |
60 | RPS6KA4 | 0.67391207 |
61 | GRK7 | 0.67241238 |
62 | NUAK1 | 0.64057861 |
63 | EPHA3 | 0.62313217 |
64 | EIF2AK3 | 0.62076972 |
65 | PIM2 | 0.61852818 |
66 | BCKDK | 0.61341981 |
67 | MAP2K6 | 0.60167886 |
68 | TSSK6 | 0.58386261 |
69 | EPHB1 | 0.58365552 |
70 | MKNK2 | 0.57754479 |
71 | MAPK7 | 0.56111464 |
72 | MAP3K1 | 0.52754346 |
73 | PRKCH | 0.52172550 |
74 | CDK4 | 0.51737614 |
75 | MAP3K3 | 0.51410907 |
76 | SCYL2 | 0.50292810 |
77 | MAP4K2 | 0.48957772 |
78 | EIF2AK2 | 0.48266260 |
79 | MAPK12 | 0.47916868 |
80 | LRRK2 | 0.46127665 |
81 | ZAK | 0.45578224 |
82 | TESK2 | 0.45377774 |
83 | NEK9 | 0.41749954 |
84 | RIPK4 | 0.41733686 |
85 | BMPR2 | 0.40890848 |
86 | CAMKK1 | 0.40478612 |
87 | STK24 | 0.40048051 |
88 | EEF2K | 0.39795633 |
89 | ADRBK2 | 0.37814935 |
90 | IGF1R | 0.37590076 |
91 | MUSK | 0.36966770 |
92 | EIF2AK1 | 0.36947219 |
93 | SRPK1 | 0.36656531 |
94 | MAP3K7 | 0.36228354 |
95 | CDK9 | 0.35341761 |
96 | PRKD2 | 0.34436430 |
97 | HIPK2 | 0.33886114 |
98 | STK4 | 0.33603758 |
99 | TLK1 | 0.31162598 |
100 | MAPK11 | 0.30712544 |
101 | IRAK2 | 0.30470539 |
102 | FYN | 0.30332790 |
103 | PASK | 0.29858835 |
104 | EGFR | 0.28991951 |
105 | ABL1 | 0.27084909 |
106 | RPS6KA5 | 0.26944558 |
107 | YES1 | 0.25357188 |
108 | * PRKCD | 0.24672920 |
109 | MAPK4 | 0.24663827 |
110 | MAPK3 | 0.23886409 |
111 | VRK1 | 0.23794546 |
112 | TGFBR1 | 0.23643251 |
113 | TRPM7 | 0.23195107 |
114 | MELK | 0.22977778 |
115 | ATR | 0.22680872 |
116 | INSR | 0.22471568 |
117 | CDK6 | 0.22429350 |
118 | MAPKAPK2 | 0.22061089 |
119 | CDC7 | 0.20435204 |
120 | RPS6KA6 | 0.19935354 |
121 | PDK1 | 0.19796378 |
122 | MAP3K5 | 0.18458839 |
123 | RPS6KL1 | 0.17677253 |
124 | RPS6KC1 | 0.17677253 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.75651620 |
2 | Allograft rejection_Homo sapiens_hsa05330 | 3.75627975 |
3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.68279992 |
4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.43929523 |
5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.12107450 |
6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.06284112 |
7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.80603432 |
8 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.80424554 |
9 | Measles_Homo sapiens_hsa05162 | 2.71361815 |
10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.58625475 |
11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.49840934 |
12 | Leishmaniasis_Homo sapiens_hsa05140 | 2.26202065 |
13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.16097539 |
14 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.95261683 |
15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.92088254 |
16 | Asthma_Homo sapiens_hsa05310 | 1.80999300 |
17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.77126651 |
18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.65561799 |
19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.63873491 |
20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.63766661 |
21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.60740785 |
22 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.52470295 |
23 | Viral myocarditis_Homo sapiens_hsa05416 | 1.41308269 |
24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.34421690 |
25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.32656099 |
26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.30681902 |
27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.26543309 |
28 | Malaria_Homo sapiens_hsa05144 | 1.25192134 |
29 | Influenza A_Homo sapiens_hsa05164 | 1.22013130 |
30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.15910467 |
31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.11217614 |
32 | DNA replication_Homo sapiens_hsa03030 | 1.10757673 |
33 | Hepatitis B_Homo sapiens_hsa05161 | 1.09337799 |
34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.08982939 |
35 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.04332331 |
36 | Ribosome_Homo sapiens_hsa03010 | 1.03173476 |
37 | Apoptosis_Homo sapiens_hsa04210 | 1.01715452 |
38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.00683329 |
39 | Base excision repair_Homo sapiens_hsa03410 | 0.98782695 |
40 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.96603981 |
41 | Legionellosis_Homo sapiens_hsa05134 | 0.94923236 |
42 | Shigellosis_Homo sapiens_hsa05131 | 0.94073882 |
43 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.91465835 |
44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.90730032 |
45 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.89240993 |
46 | Tuberculosis_Homo sapiens_hsa05152 | 0.88941598 |
47 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.86277374 |
48 | Homologous recombination_Homo sapiens_hsa03440 | 0.85241743 |
49 | HTLV-I infection_Homo sapiens_hsa05166 | 0.83152189 |
50 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.82143835 |
51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.80590585 |
52 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.78651869 |
53 | Phagosome_Homo sapiens_hsa04145 | 0.78349819 |
54 | Hepatitis C_Homo sapiens_hsa05160 | 0.75520271 |
55 | Pertussis_Homo sapiens_hsa05133 | 0.74709310 |
56 | Mismatch repair_Homo sapiens_hsa03430 | 0.73319326 |
57 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.71597433 |
58 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69521995 |
59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68571902 |
60 | Spliceosome_Homo sapiens_hsa03040 | 0.68404496 |
61 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.67329780 |
62 | Platelet activation_Homo sapiens_hsa04611 | 0.66837151 |
63 | Salmonella infection_Homo sapiens_hsa05132 | 0.66834748 |
64 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.63822721 |
65 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61651177 |
66 | RNA degradation_Homo sapiens_hsa03018 | 0.57145999 |
67 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.55633598 |
68 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.55544546 |
69 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.54239913 |
70 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53166522 |
71 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.52502961 |
72 | Other glycan degradation_Homo sapiens_hsa00511 | 0.51861087 |
73 | Lysosome_Homo sapiens_hsa04142 | 0.50874290 |
74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.49839618 |
75 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.46910968 |
76 | Colorectal cancer_Homo sapiens_hsa05210 | 0.45904414 |
77 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44396854 |
78 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.42894219 |
79 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.41397083 |
80 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.39339204 |
81 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38708013 |
82 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.37745353 |
83 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.33768449 |
84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31929199 |
85 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.31920627 |
86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.31894053 |
87 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.31101350 |
88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.30550275 |
89 | Thyroid cancer_Homo sapiens_hsa05216 | 0.30459715 |
90 | Basal transcription factors_Homo sapiens_hsa03022 | 0.30195106 |
91 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.30134729 |
92 | RNA polymerase_Homo sapiens_hsa03020 | 0.29559680 |
93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29407238 |
94 | Endocytosis_Homo sapiens_hsa04144 | 0.27731576 |
95 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.26163879 |
96 | Cell cycle_Homo sapiens_hsa04110 | 0.25830542 |
97 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.25676578 |
98 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.25220015 |
99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.24190560 |
100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.24060598 |
101 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.22441996 |
102 | Proteasome_Homo sapiens_hsa03050 | 0.22087372 |
103 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21732438 |
104 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.21161543 |
105 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.20954605 |
106 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.20318527 |
107 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.19719393 |
108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18431570 |
109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.18206706 |
110 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.17961904 |
111 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.17109832 |
112 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.17048071 |
113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15692939 |
114 | Insulin resistance_Homo sapiens_hsa04931 | 0.12694780 |
115 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.11744956 |
116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.10943637 |
117 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.10029595 |
118 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.06746642 |
119 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.06345384 |
120 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.04332251 |
121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.03848848 |
122 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.03484758 |
123 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.02834423 |
124 | Alcoholism_Homo sapiens_hsa05034 | 0.02537557 |
125 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.02388810 |